Myelin Imaging in Concussed High School Football Players
NCT ID: NCT03698747
Last Updated: 2020-09-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
13 participants
OBSERVATIONAL
2018-09-04
2020-08-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Myelin Imaging Changes In Patients With Neurosurgical Diseases
NCT03698838
Testing mTBI in Athletes
NCT02486003
Screening Brain MRI in High School Football: Does the Guardian Cap Reduce the Risk of Traumatic Brain Injury
NCT02757053
Objective Brain Function Assessment of mTBI/Concussion in College Athletes
NCT02477943
Objective Brain Function Assessment of mTBI/Concussion in High School Athletes
NCT02661633
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Rather, the data have to be post-processed by a computer in order to be able to derive myelin information. The mcDESPOT sequences are FDA approved, and present no additional risk over traditional clinical MRI sequences. Apolipoprotein E (ApoE) is a class of proteins involved in the metabolism of fats in the body, and is important in Alzheimer's disease and cardiovascular disease. How the body makes this protein is genetically coded in the APoE gene. One form of this gene, APoE allele 4 (APoE4) is found in about 25% of the population, but in 60% of patients with Alzheimer's dementia. Infants with this allele also show decreased myelination at a young age. It is postulated that this defect affects the brain's ability to myelinate and remyelinate, leading to decreased or disorganized myelination, which then leads to an increased risk for development of dementia. This study aims to build upon preliminary data collected by the principal investigator (PI) showing increased but disorganized myelin in collegiate football players, by confirming and reproducing these results in a larger population. This study will also add the component of genetic testing for the APoE4 allele to see if there is a sub-segment of the study population that may be at increased risk for brain injury after mTBI and subsequent findings in the research scans. The mcDESPOT and genetic testing findings will also be correlated with routine neuropsychology concussion assessment results.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
mTBI Study Group with McDESPOT sequence
Study group (30 subjects) of football players diagnosed with mTBI (scan at diagnosis, 3-month follow-up scan, genetic screening, concussion assessment at both interaction)
McDESPOT
myelin specific MRI sequence (mcDESPOT) added to standard MRI sequence
Control Group
Control group (30 subjects) of age match non-contact sport players (scan, genetic testing, concussion assessment)
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
McDESPOT
myelin specific MRI sequence (mcDESPOT) added to standard MRI sequence
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient age range: 9th through 12th grade (high school)
* Male
* Right-handed
* Diagnosis of mTBI or concussion during a football game or training
* No significant co-morbidities
* Able to get an MRI
* Potential subject must be capable of giving informed consent or assent when applicable
• Control Group
* Patient age range: 9th through 12th grade (high school)
* Male Right-handed
* Does not play contact sports (football, soccer, lacrosse)
* No significant co-morbidities
* Able to get an MRI
* Potential subject must be capable of giving informed consent or assent when applicable
Exclusion Criteria
13 Years
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Memorial Healthcare System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Heather Spader, MD
Role: PRINCIPAL_INVESTIGATOR
Memorial Healthcare System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial Healthcare System
Hollywood, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MTBI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.